Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche bearbeiten
Filter bei nächster Suche beibehalten
publishDate:"[2019 TO 2021]"
journalStr:"WHO International Clinical Trials Registry Platform"
topic_facet:"Phase: Phase 2"
topic_facet:"Medical Condition: Severe pulmonary COVID-19 related disease MedDRA version: 23.0Level: LLTClassification code 10053983Term: Corona virus infectionSystem Organ Class: 100000004862;Therapeutic area: Diseases [C] - Virus Diseases [C02]"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2019+TO+2021%5D%22&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Severe+pulmonary+COVID-19+related+disease+MedDRA+version%3A+23.0Level%3A+LLTClassification+code+10053983Term%3A+Corona+virus+infectionSystem+Organ+Class%3A+100000004862%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Virus+Diseases+%5BC02%5D%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22novel+coronavirus%22+OR+Covid+OR+%22Sars-CoV%22+OR+%22CoV-2%22+OR+ncov&type0%5B%5D=AllFields&op0%5B%5D=OR
/vufind/Search/Results?filter%5B%5D=publishDate%3A%22%5B2019+TO+2021%5D%22&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Severe+pulmonary+COVID-19+related+disease+MedDRA+version%3A+23.0Level%3A+LLTClassification+code+10053983Term%3A+Corona+virus+infectionSystem+Organ+Class%3A+100000004862%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Virus+Diseases+%5BC02%5D%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22novel+coronavirus%22+OR+Covid+OR+%22Sars-CoV%22+OR+%22CoV-2%22+OR+ncov&type0%5B%5D=AllFields&op0%5B%5D=OR
Search /vufind/Search2/Results?filter%5B%5D=publishDate%3A%22%5B2019+TO+2021%5D%22&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&filter%5B%5D=topic_facet%3A%22Medical+Condition%3A+Severe+pulmonary+COVID-19+related+disease+MedDRA+version%3A+23.0Level%3A+LLTClassification+code+10053983Term%3A+Corona+virus+infectionSystem+Organ+Class%3A+100000004862%3BTherapeutic+area%3A+Diseases+%5BC%5D+-+Virus+Diseases+%5BC02%5D%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22novel+coronavirus%22+OR+Covid+OR+%22Sars-CoV%22+OR+%22CoV-2%22+OR+ncov&type0%5B%5D=AllFields&op0%5B%5D=OR
PubPharm (8)
1
Investigating otilimab in patients with severe coronavirus related lung disease. : A randomized, double-blind, placebo-controlled, study evaluating the efficacy and safety of otilimab IV in patients with severe pulmonary COVID-19 related disease. - OSCAR
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
2
Investigating otilimab in patients with severe coronavirus related lung disease. : A randomized, double-blind, placebo-controlled, study evaluating the efficacy and safety of otilimab IV in patients with severe pulmonary COVID-19 related disease. - OSCAR
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
3
Investigating otilimab in patients with severe coronavirus related lung disease. : A randomized, double-blind, placebo-controlled, study evaluating the efficacy and safety of otilimab IV in patients with severe pulmonary COVID-19 related disease. - OSCAR
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
4
Investigating otilimab in patients with severe coronavirus related lung disease. : A randomized, double-blind, placebo-controlled, study evaluating the efficacy and safety of otilimab IV in patients with severe pulmonary COVID-19 related disease. - OSCAR
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
5
Investigating otilimab in patients with severe coronavirus related lung disease. : A randomized, double-blind, placebo-controlled, study evaluating the efficacy and safety of otilimab IV in patients with severe pulmonary COVID-19 related disease. - OSCAR
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
6
Investigating otilimab in patients with severe coronavirus related lung disease. : A randomized, double-blind, placebo-controlled, study evaluating the efficacy and safety of otilimab IV in patients with severe pulmonary COVID-19 related disease. - OSCAR
enthalten in:
WHO International Clinical Trials Registry Platform
| 2021
Wird geladen...
7
Investigating otilimab in patients with severe coronavirus related lung disease. : A randomized, double-blind, placebo-controlled, study evaluating the efficacy and safety of otilimab IV in patients with severe pulmonary COVID-19 related disease. - OSCAR
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
8
Investigating otilimab in patients with severe coronavirus related lung disease. : A randomized, double-blind, placebo-controlled, study evaluating the efficacy and safety of otilimab IV in patients with severe pulmonary COVID-19 related disease. - OSCAR
enthalten in:
WHO International Clinical Trials Registry Platform
| 2020
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Alle gewählten Filter entfernen
Filter aufheben
Erscheinungsjahr: 2019-2021
Filter aufheben
Zeitschrift: WHO International Clinical Trials Registry Platform
Filter aufheben
Thema: Phase: Phase 2
Filter aufheben
Thema: Medical Condition: Severe pulmonary COVID-19 related disease MedDRA version: 23.0Level: LLTClassification code 10053983Term: Corona virus infectionSystem Organ Class: 100000004862;Therapeutic area: Diseases [C] - Virus Diseases [C02]
Medienart
8
Aufsätze
8
E-Artikel
8
E-Ressourcen
Zeitschriftentitel
WHO International Clinical Trials Registry Plat...
Thema
8
610
Medical Condition: Severe pulmonary COVID-19 re...
Phase: Phase 2
8
Study Type: Interventional
4
Recruitment Status: Authorised-recruitment may ...
4
Recruitment Status: Not yet recruiting
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2019-2021
6
2021
2
2020
Erscheinungsjahr(e)
Von:
Bis:
Sprache
8
Englisch
Haven't found what you're looking for?
Wird geladen...